Market Views – Page 17 – media

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Orthotaxy’s Technology Will Be Leveraged to Develop Cost-Effective, Time-Efficient, User-Friendly Offering in a Broad Range of Orthopaedics Procedures.
- Source: Jnj
- 521
- February 27, 2018
Market Views Orthopaedics
Gilead links with Sangamo in gene therapy alliance

Gilead’s Kite is linking with Sangamo Therapeutics in a collaboration that aims to develop next-generation engineered cell therapies for the treatment of cancer.
- Source: drugdu
- 545
- February 26, 2018
cancer engineered cell therapies Gilead Market Views
AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and Tencent

XtalPi Inc., a computation-driven pharmaceutical technology company, announced that it has closed a Series B funding round of 15 million USD led by Sequoia China, with participation from Google and existing investor Tencent. To date, XtalPi has raised over 20 million USD, making it one of the top-funded AI-powered biotechs.
- Source: finance.yahoo
- 521
- February 26, 2018
biotechs Market Views Series
Merck Drops $394 Million to Acquire Virus-Based Cancer Company Viralytics

Merck & Company is driving forward in its quest to develop a premier immuno-oncology pipeline. The company plunked down $394 million to acquire Australia-based Viralytics Ltd and its oncolytic immunotherapy treatments.
- Source: Biospace;
- 725
- February 26, 2018
immuno-oncology pipelin immunotherapy Market Views Merk
What’s Driving the Global Surgical Robotics Market

According to a new market research report by BIS Research, the global surgical robotics market is expected to reach a value of $12.6 billion by the year 2025.
- Source: marketresearch.com
- 1,220
- February 26, 2018
healthcare technologies and innovations Market Reports Market Views surgical
Priority review for Shire’s HAE drug

US regulators are undertaking a speedy review of Shire’s lanadelumab (SHP643) for the prevention of angioedema attacks in patients 12 years and older with hereditary angioedema (HAE).
- Source: pharmatimes
- 779
- February 24, 2018
angioedema HAE Market Views
How to overcome digital documentation challenges in health care

The mobile health industry is exploding, and it’s not just because more Americans than ever own smart devices. Providers and patients alike are realizing real value in mobile health technology as advancements ease the path to greater efficiency and lower costs.
- Source: healthcarebusinesstech
- 564
- February 24, 2018
Market Views mobile health smart devices
NICE sticks with ‘no’ for earlier use of Halaven

Cost regulators for NHS treatments in England and Wales are sticking with their position that Eisai’s Halaven should not be funded by the NHS as a second-line of attack against a certain form of breast cancer.
- Source: pharmatimes
- 1,831
- February 23, 2018
breast cancer Market Views NHS
Medical device product development– 7 pitfalls you need to avoid

Managing your medical device product development project can be a daunting task. There are regulations and paperwork to manage, along with expectations such as deadlines or goals for getting the device to market.
- Source: medicaldesignandoutsourcing
- 614
- February 14, 2018
Market Views medical device
Could AI One Day Detect the Flu…Before You Even Feel Sick?

It’s flu season, and many of us find ourselves glancing nervously at anyone coughing or sniffling in our vicinity. But how, besides shielding ourselves from public sneezers, do we avoid coming into contact with infections?
- Source: smithsonianmag
- 625
- February 14, 2018
AI flu Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.